 HIV Infections
"HIV Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
| Descriptor ID |
D015658
|
| MeSH Number(s) |
C02.782.815.616.400 C02.800.801.400 C20.673.480
|
| Concept/Terms |
HIV Infections- HIV Infections
- HIV Infection
- Infection, HIV
- Infections, HIV
- HTLV-III-LAV Infections
- HTLV III LAV Infections
- HTLV-III-LAV Infection
- Infection, HTLV-III-LAV
- Infections, HTLV-III-LAV
- T-Lymphotropic Virus Type III Infections, Human
- T Lymphotropic Virus Type III Infections, Human
- HTLV-III Infections
- HTLV III Infections
- HTLV-III Infection
- Infection, HTLV-III
- Infections, HTLV-III
HIV Coinfection- HIV Coinfection
- Coinfection, HIV
- Coinfections, HIV
- HIV Coinfections
|
Below are MeSH descriptors whose meaning is more general than "HIV Infections".
Below are MeSH descriptors whose meaning is more specific than "HIV Infections".
This graph shows the total number of publications written about "HIV Infections" by people in this website by year, and whether "HIV Infections" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 6 | 0 | 6 | | 1997 | 2 | 2 | 4 | | 1998 | 16 | 3 | 19 | | 1999 | 16 | 4 | 20 | | 2000 | 24 | 3 | 27 | | 2001 | 19 | 2 | 21 | | 2002 | 20 | 7 | 27 | | 2003 | 15 | 11 | 26 | | 2004 | 42 | 9 | 51 | | 2005 | 35 | 6 | 41 | | 2006 | 39 | 3 | 42 | | 2007 | 45 | 8 | 53 | | 2008 | 42 | 4 | 46 | | 2009 | 46 | 7 | 53 | | 2010 | 46 | 15 | 61 | | 2011 | 75 | 10 | 85 | | 2012 | 53 | 13 | 66 | | 2013 | 78 | 13 | 91 | | 2014 | 103 | 11 | 114 | | 2015 | 77 | 10 | 87 | | 2016 | 101 | 11 | 112 | | 2017 | 98 | 12 | 110 | | 2018 | 108 | 14 | 122 | | 2019 | 115 | 14 | 129 | | 2020 | 110 | 6 | 116 | | 2021 | 146 | 5 | 151 | | 2022 | 135 | 3 | 138 | | 2023 | 105 | 1 | 106 | | 2024 | 104 | 6 | 110 | | 2025 | 81 | 12 | 93 | | 2026 | 68 | 3 | 71 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV Infections" by people in Profiles.
-
Haw NJL, Hogan B, Humes E, Coburn SB, Zheng C, Cheng Y, Zhang Y, Gebo KA, Lam JO, Karris MY, Zalla LC, Horberg MA, Napravnik S, Gill MJ, Althoff KN, Lesko CR. New to cohort, not new to care: leveraging historical data in HIV clinical cohorts in the United States. Am J Epidemiol. 2026 Aug 05; 195(8):2287-2296.
-
Wu Q, Karim S, Van MT, Enns B, Guerra-Alejos BC, Marshall BDL, Schackman BR, Del Rio C, Behrends CN, Enns E, Tookes HE, Rosen-Metsch L, Golden M, Strathdee SA, Mehta SH, Armstrong WS, Nosyk B, Zang X. Effect of COVID-19 on Late HIV Diagnosis Rates by Race/Ethnicity in Ending the HIV Epidemic Priority Jurisdictions in the United States. J Acquir Immune Defic Syndr. 2026 Aug 01; 101(8):803-811.
-
Kasirye R, Yang P, White JL, Tassiopoulos K, Granche J, Chauhan L, Nakabiito C, Fowler MG, Tobian AAR, Musoke P, Erlandson KM. Hospitalization Rates and Associated Factors Among Older Adults With HIV in the United States. J Acquir Immune Defic Syndr. 2026 Aug 01; 101(8):836-843.
-
King HAD, Subra C, Tourtellott E, Swafford I, Basu S, Rossman M, Phillips L, Obarorakpor N, Ding S, Ferrari MG, Beck Z, Lewitus E, Bai H, Dong M, Slike BM, Kim D, Dussupt V, Mendez-Rivera L, Eisel N, Zhang L, Williams LD, Tomaras GD, Finzi A, Matyas GR, Krebs SJ, Rolland M, Rao M, Paquin-Proulx D, Bolton DL. Rapid and robust immune response boosting with potent, next-generation adjuvant in viral vector-primed primates. J Virol. 2026 Aug 18; 100(8):e0038926.
-
Koethe JR, Lake JE, Kantor A, Smeaton L, Erlandson K, Moran L, Belaunzaran-Zamudio P, Landay A, Campo RE, Debroy P, Bennet JA, O'Halloran J, Han WM, Alli O, Leonard M, Gulick RM. A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391). Clin Infect Dis. 2026 Jul 23; 83(1):e81-e89.
-
Iriarte E, Erlandson KM. Interventions and opportunities to enhance aging among people with HIV: a focus on frailty, sarcopenia, and intrinsic capacity. Top Antivir Med. 2026 Jul 16; 34(3):554-560.
-
Puccinelli M, Mayer KH, Esquivel-Mendoza JA, Porras A, Psaros C, Krakower D, Doblecki-Lewis S, Anderson PL, Mimiaga MJ, Safren SA. Life-steps for PrEP nurse-delivered adherence intervention: Protocol for a multisite randomized clinical trial. Contemp Clin Trials. 2026 Sep; 168:108405.
-
Ridolfi F, Amorim G, Haas DW, Arriaga M, Staats C, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Andrade BB, Sterling TR, Rolla VC, Benjamin A, Sant'Anna FM, Oliveira JG, Marin J, Rezende A, Carvalho AC, Rocha M, Nogueira B, Brito A, Spener R, Turner M. Determinants of HIV-1 virologic suppression in HIV-associated tuberculosis in Brazil. Mem Inst Oswaldo Cruz. 2026; 121:e250090.
-
Lee JS, Humes E, Haw NJL, Hogan B, Zheng C, Coburn S, Lesko CR, Lang R, Gill MJ, Horberg M, Silverberg MJ, Palella FJ, Delaney JA, Rebeiro PF, Sterling T, Rodriguez-Barradas M, Marconi VC, Yendewa GA, Klein MB, Moore R, Althoff KN. Harmonizing HIV-1 RNA laboratory measurements in a longitudinal cohort collaboration. Am J Epidemiol. 2026 07 08; 195(7):2055-2063.
-
Gonzalez H, Ridgeway K, Shorer EF, Dastgheyb R, Rajagopal R, Cao Y, Morack R, Hahm E, Weber KM, Rubin LH, French AL. Plasma suPAR and domain-specific cognitive performance in virologically suppressed women with HIV. J Neurovirol. 2026 Jul 08; 32(4).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|